 |
市场调查报告书
商品编码
1747611
生物製药 CMO 和 CRO 市场（按材料、服务、产品和地区）Biopharmaceutical CMO and CRO Market, By Source, By Service, and By Product, and By Geography |
||||||
价格
简介目录
生物製药 CMO 和 CRO 市场规模预计在 2025 年达到 406 亿美元，预计到 2032 年将达到 606.5 亿美元，2025 年至 2032 年的复合年增长率为 5.9%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 406亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 5.90% | 2032年价值预测 | 606.5亿美元 |
生物製药CMO（受託製造厂商）是一家以合约为基础的公司，为生物製药领域的其他公司提供服务，从药品製造服务到包装；而CRO（委外研发机构）是一家以委託研究服务的形式为生物製药公司提供支援的公司。
市场动态：
慢性病的增加、药物发现和开发的增加、对生技药品和生物仿製药的需求增加、外包趋势的上升、研发投资的增加以及生物製药行业的快速增长是预计推动全球生物製药 CMO 和 CRO 市场成长的关键因素。
例如，2023年2月，Lunaphor与SironaDx宣布达成策略合作，SironaDx将成为第一个提供Lunaphor旗舰产品COMET空间生物学平台即服务的美国合约研究组织（CRO）。 COMET是对SironaDx委外研发机构组合的补充，旨在满足跨学科研究人员和生物製药团队的需求。 COMET服务于跨学科、涵盖研究和药物开发各个阶段的广泛研究应用。
本研究的主要特点
- 本报告对全球生物製药 CMO 和 CRO 市场进行了详细分析，并以 2024 年为基准年，提供了 2025 年至 2032 年预测期内的市场规模和年复合成长率（CAGR%）。
- 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球生物製药 CMO 和 CRO 市场中主要企业的概况。
- 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、高端市场策略、市场扩张和行销策略做出明智的决策。
- 全球生物製药 CMO 和 CRO 市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过分析全球生物製药 CMO 和 CRO 市场所使用的各种策略矩阵来简化决策。
目录：
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 全球外包趋势日益成长
- 严格的法规结构
- 生物製药产业快速成长
- 影响分析
- 主要亮点
- 监管情景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
4. 全球生物製药 CMO 和 CRO 市场（按来源划分），2020 年至 2032 年
- 哺乳动物
- 非哺乳动物
5. 2020 年至 2032 年全球生物製药 CMO 和 CRO 市场（按服务划分）
- 契约製造
- 合约研究
6. 2020 年至 2032 年全球生物製药 CMO 与 CRO 市场（依产品划分）
- 生物製剂
- 生物相似药
7. 2020 年至 2032 年全球生物製药 CMO 与 CRO 市场（按地区）
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第八章 竞争态势
- Allphase Clinical Research
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials（ACT）
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology
第九章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI5933
Biopharmaceutical CMO and CRO Market is estimated to be valued at USD 40.6 Bn in 2025 and is expected to reach USD 60.65 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 40.6 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.90% | 2032 Value Projection: | USD 60.65 Bn |
Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.
Market Dynamics:
Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.
For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.
Key features of the study:
- This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.
Detailed Segmentation:
- Global Biopharmaceutical CMO and CRO Market, By Source:
- Mammalian
- Non-mammalian
- Global Biopharmaceutical CMO and CRO Market, By Service:
- Contract Manufacturing
- Contract Research
- Global Biopharmaceutical CMO and CRO Market, By Product:
- Biologics
- Biosimilars
- Global Biopharmaceutical CMO and CRO Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles:
- Allphase Clinical Research
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials (ACT)
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Service
- Market Snapshot, By Product
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing trend of outsourcing across the globe
- Stringent regulatory framework
- Rapid growth of the biopharmaceutical industry
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Biopharmaceutical CMO and CRO Market, By Source, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Non-mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
5. Global Biopharmaceutical CMO and CRO Market, By Service, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Biopharmaceutical CMO and CRO Market, By Product, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Biopharmaceutical CMO and CRO Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Allphase Clinical Research
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AlcheraBio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alcami
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Akos Urgent Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Affinity Life Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Actimus Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ACI Clinical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accumedix, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Absorption Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- A10 Clinical Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Albuquerque Clinical Trials (ACT)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ajinomoto Bio-Pharma Services
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Advanced Clinical Services LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ACM Global Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accelerated Enrollment Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Contract Manufacturing
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Advanced BioScience Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Advanced Clinical Research Institute
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alliance for Clinical Trials in Oncology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
双特异性抗体治疗合约製造市场－全球产业规模、份额、趋势、机会和预测（按适应症、给药途径、最终用途、地区和竞争细分，2020-2030 年预测）
抗体受託製造市场:被製造的抗体类别，所使用的表现系统类别，各产业规模，各地区
全球生物分解性药品包装市场：按材料、产品类型、最终用户、应用、区域范围和预测2026 年至 2032 年医药契约製造和合约研究市场（按服务类型、最终用户和地区划分）
美国生物製药契约製造市场：市场规模、份额、趋势分析（按原材料、服务、产品、类型、业务规模和治疗领域）、细分市场预测（2025-2030 年）
医药契约製造和研究服务市场（按服务类型和最终用户）—2025-2030 年全球预测医药无菌转移市场（依产品、技术、系统类型、可用性、灭菌方法、最终用途和应用）－2025-2030 年全球预测合约研究与製造服务市场（按服务类型、技术、治疗领域、应用和最终用户划分）—2025 年至 2030 年全球预测契约製造市场按产品类型、原材料、合约期限、技术、客户类型、服务类型和最终行业划分－2025-2030 年全球预测医药品受託製造市场:2025-2035年
▼